People with diabetes with coronavirus infection have a high likelihood of progression to severe COVID-19. The pandemic has upset our health model; the booking suspension limited access to emergencies, made it difficult to guarantee medical services, with different access priorities, to assist chronic patients, such as diabetics, for whom discontinuity of care could become a risk for and in case of infection. In ASLTO3 we have developed an emergency procedure, in compliance with the lockdown provisions to limit the presence in the clinic, for the provision of services, in presence or at a distance, to people with diabetes blocked at home, or in isolation, hospitalized or quarantined, or to be hospitalized. We have developed a strategy based on the diabetes care pathway PDTA, standard of care in Piedmont, to stratify the risk of loss of access to services and to prepare organizational measures to select, case by case, the relative and deferred urgent requests, direct on the right location for the right answer giving priority to those who still did not know or already knew they had diabetes, even positive for COVID-19, and needed treatment, and uses dedicated telephone lines and e-mails, for a virtual clinic. During the first peak of the pandemic, we assisted over 4000 people with diabetes by providing 7598 services, 244 for endocrinology, 7199 for diabetes, 155 consultations, 431 face-to-face and over 5,000 remotes. Studies produced during the COVID-19 emergency have confirmed that the active resilience of the diabetes care service can help improve patient outcomes and system stability. Experience in the implementation of technologies, such as diabetes PDTA, adapted to the emergency, can help to triage both persons, activities, prevention and assistance, and telemedicine projects to minimize the risk in future events. KEY WORDS pandemic COVID-19; diabetes care pathway; medical services; triage patient; telemedicine.
Read full abstract